Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Adhoc Press Release
Kuros Biosciences Reports Results for First Half 2023
Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial